Blog

Sep 8, 2024, 09:00

Joe Y. Chang: Join the WCLC brain metastases discussion

Joe Y. Chang, Director of Stereotactic Ablative Radiotherapy Program at MD Anderson Cancer Center, shared a post on X:

“Brain metastases used to be an ’emergency.’ Stereotactic radiosurgery (SRS) has replaced whole brain radiation therapy (WBRT) for lesions up to 10. In the era of newer generation tyrosine kinase inhibitors (TKIs), there is a need to balance local control (LC) versus the toxicities of brain radiation therapy (RT). We need both cutting-edge technology and novel biology. We welcome you to join our WCLC brain metastases discussion on September 9, 2024.”

Joe Y. Chang

Source: Joe Y. Chang/X

brain metastases cancer Joe Y Chang MD Anderson Cancer Center OncoDaily Oncology radiation therapy stereotactic radiosurgery WCLC whole brain radiation therapy

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage